MIRA INFORM REPORT

 

 

Report Date :

13.04.2013

 

IDENTIFICATION DETAILS

 

Name :

PHARMA EXPRESS OPERADORA LOGÍSTICA LTDA - EPP

 

 

Registered Office :

Avenida Brasil Sul,4061 - Setor Sul Jamil Miguel 75124-820 - Anápolis/Go

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

16.07.2009

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Distribution of Packaging For Medicaments.

 

 

No. of Employees :

11

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Maximum Credit Limit:

--

Status :

Moderate

Payment Behaviour :

Slow

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% for 2011 as a whole, though forecasts for 2012 growth are somewhat higher. Despite slower growth in 2011, Brazil overtook the United Kingdom as the world's seventh largest economy in terms of GDP. Urban unemployment is at the historic low of 4.7% (December 2011), and Brazil's traditionally high level of income equality has declined for each of the last 12 years. Brazil's high interest rates make it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchanges markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint.

Source : CIA


Company name

 

PHARMA EXPRESS OPERADORA LOGÍSTICA LTDA - EPP

 

 

ADDRESSES

 

MAIN ADDRESS:

AVENIDA BRASIL SUL,4061 - SETOR SUL JAMIL MIGUEL

ZIP CODE/CITY:

75124-820 - ANÁPOLIS/GO

 

 

PHONE:

62 3313-4525

FAX:

62 3313-4525

E-MAIL:

comercial@pharmexpress.com.br

WEB SITE:

www.pharmexpress.com.br

 

BRANCHES:

 

NOT AVAILABLE.

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

DISTRIBUTION OF PACKAGING FOR MEDICAMENTS.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

16/07/2009

REGISTER DATE:

16/07/2009

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

10.977.241/0001-49

STATE REGISTER:

10.452.919-9

 

 

SHARE CAPITAL:

R$ 550.000,00

LAST REGISTER OF CAPITAL:

06/11/2012

 

BOARD OF DIRECTORS:

 

 

 

WELLINGTON FERREIRA BRANQUINHO

MANAGING PARTNER

 

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

 

SHAREHOLDERS / PARTNERS:

 

 

 

WELLINGTON FERREIRA BRANQUINHO

99%

OTEVALDO CANDIDO BRANQUINHO

1%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

WBC PRESTAÇÃO DE SERVIÇOS LTDA ME

99,00%

SEKOYA GROUP

99,00%

GEON GRÁFICA

50,00%

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON JULY 16, 2009 AS FARMA EXPRESS OPERADORA LOGÍSTICA LTDA ME TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON APRIL 19, 2010 IT ADOPTED THE ABOVE-MENTIONED NAME.

 

TRADE NAME: "PHARMA EXPRESS ".

 

PARTNERS:

 

WELLINGTON FERREIRA BRANQUINHO, BRAZILIAN, SINGLE, HOLDER OF DOCUMENTS, CPF 695.495.401-20 AND RG 3.611.212 DGPC/GO, RESIDENTIAL ADDRESS AT RUA 10, QD. 1,, LT. 3, BAIRRO JARDIM PETRÓPOLIS - ANÁPOLIS/GO;

 

OTEVALDO CANDIDO BRANQUINHO, BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS, CPF 015.062.421-20 AND RG 473.599-2ª VIA SSP/GO, RESIDENTIAL ADDRESS AT RUA 10, QD. 1,, LT. 3, BAIRRO JARDIM PETRÓPOLIS - ANÁPOLIS/GO.

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2011.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2011

 

 

 

 

 

 

CASH AND BANKS

77.712,60

 

 

CLIENTS

152.690,13

 

 

IMPORTS IN PROGRESS

231.870,47

 

 

ADVANCE TO SUPPLIERS

315.189,42

 

 

ADVANCE TO EMPLOYEES

561,31

 

 

INVENTORY

1.394.383,08

 

 

RECOVERABLE TAXES

29.833,14

 

 

PRE PAID EXPENSES

12.634,00

 

 

 

----------------

 

 

TOTAL CURRENT ASSETS

2.214.874,15

 

 

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

151.509,49

 

 

 

----------------

 

 

TOTAL FIXED ASSETS

151.509,49

 

 

 

================

 

 

TOTAL ASSETS

2.366.383,64

 

 

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2011

 

 

 

 

 

 

LOANS AND FINANCING

178.911,16

 

 

SUPPLIERS

250.102,86

 

 

TRIBUTARY OBLIGATIONS

50.553,99

 

 

SOCIAL / LABOR OBLIGATIONS

24.200,38

 

 

ACCOUNTS PAYABLE

447.470,67

 

 

SALES FOR FUTURE DELIVERY

871.619,80

 

 

DEBT WITH PARTNERS

567.315,08

 

 

 

----------------

 

 

TOTAL CURRENT LIABILITIES

2.390.173,94

 

 

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

50.000,00

 

 

ACCRUED PROFIT (LOSS)

-73.790,30

 

 

 

----------------

 

 

TOTAL NET EQUITY

-23.790,30

 

 

 

================

 

 

TOTAL LIABILITIES

2.366.383,64

 

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2011.

( FIGURES ARE IN REAIS ).

 

 

31/12/2011

 

 

 

 

 

 

GROSS SALES

1.356.643,34

 

 

(-) TAXES ON SALES

258.590,72

 

 

 

----------------

 

 

NET SALES

1.098.052,62

 

 

(-) COST OF SOLD GOODS

634.955,83

 

 

 

----------------

 

 

GROSS PROFIT

463.096,79

 

 

OPERATING REVENUE (EXPENSE)

-517.622,75

 

 

FINANCIAL REVENUE(EXPENSE)

-18.916,18

 

 

 

----------------

 

 

OPERATIONAL PROFIT (LOSS)

-73.442,14

 

 

CONTRIBUTION/INCOME TAX

-37.780,10

 

 

 

----------------

 

 

NET PROFIT (LOSS)

-111.222,24

 

 

 

MONTHLY SALES

 

  2012

 

 

 

---------------------

 

 

JANUARY

R$ 325.083,76

 

 

FEBRUARY

R$ 219.924,17

 

 

MARCH

R$ 233.681,36

 

 

APRIL

R$ 219.665,21

 

 

MAY

R$ 312.001,03

 

 

JUNE

R$ 128.827,26

 

 

JULY

R$ 193.819,24

 

 

AUGUST

R$ 194.361,14

 

 

SEPTEMBER

R$ 186.631,55

 

 

OCTOBER

R$ 174.416,71

 

 

NOVEMBER

R$ 197.774,66

 

 

DECEMBER

R$ 207.878,66

 

 

TOTAL

R$ 2.594.064,75

 

 

 

RATIOS:

31/12/2011

 

 

 

QUICK RATIO

,34

 

 

 

 

 

CURRENT RATIO

,93

 

 

 

 

 

ACCOUNTS RECEIVABLE TURNOVER

7,19

TIMES

 

 

 

 

DAYS' SALES IN RECEIVABLES

50,06

DAYS

 

 

 

 

INVENTORY TURNOVER

,46

TIMES

 

 

 

 

ACCOUNTS PAYABLE PERIOD

141,80

DAYS

 

 

 

 

RETURN ON ASSETS

,46

TIMES

 

 

 

 

SALES TURNOVER ON NET EQUITY

-46,16

TIMES

 

 

 

 

NET WORTH TIE-UP

-6,37

 

 

 

 

 

INDEBTEDNESS

-100,47

 

 

 

 

 

EQUITY RATIO

-1,01

%

 

 

 

 

WORKING CAPITAL RATIO

-7,33

%

 

 

 

 

GENERAL SOLVENCY

,99

 

 

 

 

 

RETURN ON NET EQUITY

467,51

%

 

 

 

 

RETURN ON SALES (PROFIT MARGIN)

-10,13

%

 

 

 

 

GROSS PROFIT MARGIN

42,17

%

 

 

 

 

OPERATIONAL RESULT

-6,69

%

 

 

 

 

SALES TURNOVER ON LIABILITIES

,46

TIMES

 

 

 

 

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 1,98

 - OFFICIAL RATE ON 10/04/2013

US$ 1,00 = R$ 1,87

 - OFFICIAL RATE ON 31/12/2011

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY IS SO FAR NOT KNOWN.

 

THE FIGURES AVAILABLE SHOW AN UNBALANCED FINANCIAL STANDING. IT SHOWS LOW LIQUIDITY RATIOS AND VERY HIGH LEVEL OF INDEBTEDNESS WITH NEGATIVE NET EQUITY AS WELL AS NEGATIVE RESULTS.

 

REAL ESTATE:

 

   NOT AVAILABLE

 

VEHICLES:

 

   NOT AVAILABLE

 

MACHINES:

 

   NOT AVAILABLE

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO DO BRASIL S/A

AG: 3485-1  /  62 3207-3200

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

DISTRIBUTION OF PACKAGING FOR MEDICAMENTS.

 

 

IMPORT AND EXPORT:

 

   IMPORTS FROM:

INDIA, CHINA AND AUSTRIA.

 

TOTAL, US$ 1.000.000,00 (ANNUALLY)

 

   EXPORTS TO:

NOT AVAILABLE.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

 

ACHÉ

 

 

CIFARMA

 

 

EQUIPLEX INDUSTRIA FARMACÊUTICA

 

 

GEOLAB

 

 

NEO QUIMICA

 

 

TEUTO

 

 

 

STAFF:

 

THE COMPANY HAS: 11 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT WAS ESTABLISHED IN 2009. SO FAR IT HAS A CLEAR TRADE HISTORY AND MODEST PAYMENT BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER OF TRADE CREDIT FACILITIES.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

 

BILCARE

 

 

CAETÉ EMBALAGENS

 

 

EMBALAGENS JAGUARÉ

 

 

GEON INDUSTRIA E COMERCIO LTDA

 

 

 

FOREIGN SUPPLIERS:

COUNTRY:

 

ACG PHARMAPACK PVT LTD

INDIA

 

SHANDOG PHARMACEUTICAL GLASS CO LTD

CHINA

 

STOLZLE OBERGLASS GMBH

AUSTRIA

 

 

PAYMENT HISTORY:

 

NO PAYMENT RECORD IS REGISTERED.

 

 

FINAL OPINION

 

BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR NORMAL BUSINESS COMMITMENTS. CREDIT FACILITIES HOWEVER SHOULD BE GRANTED ON FULLY SECURED TERMS ONLY DUE TO THE UNFAVORABLE FINANCIAL SITUATION SHOWED IN THE BALANCE SHEETS.

 

 



FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.44

UK Pound

1

Rs.83.77

Euro

1

Rs.71.33

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.